Market revenue in 2023 | USD 24.0 million |
Market revenue in 2030 | USD 27.5 million |
Growth rate | 1.9% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 22.5% in 2023. Horizon Databook has segmented the Kuwait laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
The LDT market in the country is supported by several local and international companies that offer a wide range of LDTs, including tests for infectious diseases, genetic disorders, and cancer, among others. The availability of these tests, along with advances in technology, are driving the LDTs market in Kuwait.
Despite the growth, the market faces certain challenges like limited access to new technologies in certain areas of the country. However, the increasing demand for high-quality diagnostic tests & efforts of companies to invest in new technologies and expand their offerings are expected to drive continued growth in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account